Trial Review

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/ct2/show/NCT01431001




Registration number
NCT01431001
Ethics application status
Date submitted
6/09/2011
Date registered
9/09/2011
Date last updated
19/05/2014

Titles & IDs
Public title
Pilot Study in Multi-Coil Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Depression
Scientific title
Determining Effectiveness of Multi-Coil rTMS for Patients With Major Depressive Disorder: A Pilot Study
Secondary ID [1] 0 0
NS-CPS-TRMD-1
Universal Trial Number (UTN)
Trial acronym
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Major Depressive Disorder 0 0
Condition category
Condition code
Mental Health 0 0 0 0
Depression

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Treatment: Devices - Cervel Neurotech Deep Shaped-Field repetitive transcranial magnetic stimulator (DSF-rTMS)

Experimental: Coil Configuration A - Cervel Neurotech Deep Shaped-Field repetitive transcranial magnetic stimulator (DSF-rTMS)

Experimental: Coil Configuration B - Cervel Neurotech Deep Shaped-Field repetitive transcranial magnetic stimulator (DSF-rTMS)


Treatment: Devices: Cervel Neurotech Deep Shaped-Field repetitive transcranial magnetic stimulator (DSF-rTMS)
The Cervel Neurotech Deep Shaped-Field repetitive transcranial magnetic stimulator is an investigational rTMS device
Intervention code [1] 0 0
Treatment: Devices
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Remission from depression
Timepoint [1] 0 0
baseline through 4 weeks post
Secondary outcome [1] 0 0
Safety and tolerability of rTMS
Timepoint [1] 0 0
baseline through 4 weeks post

Eligibility
Key inclusion criteria
- Major depressive disorder (MDD)

- Mild to moderate level of resistance or intolerance to antidepressant treatment in the
current episode.

- Will not become pregnant during study.
Minimum age
18 Years
Maximum age
70 Years
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
- Seizure disorder.

- History of brain injury or active CNS disease.

- Metal implants on or in brain, spinal cord, ear, eye or heart.

- Current use of proconvulsant medications (e.g., bupropion).

- Other significant psychiatric disorder.

- Substance use disorder (not including caffeine or nicotine).

- 7 or more failed treatment attempts for depression in one's lifetime.

- Have failed to clinically remit to an adequate trial of ECT or TMS.

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
Not Applicable
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/10/2011
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/10/2013
Sample size
Target
Accrual to date
Final
40
Recruitment in Australia
Recruitment state(s)
VIC
Recruitment hospital [1] 0 0
Monash Alfred Psychiatry Research Centre - Melbourne
Recruitment postcode(s) [1] 0 0
3004 - Melbourne
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
Georgia
Country [2] 0 0
United States of America
State/province [2] 0 0
Illinois
Country [3] 0 0
United States of America
State/province [3] 0 0
South Carolina

Funding & Sponsors
Primary sponsor type
Commercial sector/Industry
Name
Cervel Neurotech, Inc.
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
The purpose of this study is to assess the efficacy of a Deep Shaped-Field repetitive
transcranial magnetic stimulation (DSF-rTMS) system in the treatment of depression.
Trial website
https://clinicaltrials.gov/ct2/show/NCT01431001
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
AnnaMarie Daniels
Address 0 0
Cervel Neurotech
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries



Summary Results

For IPD and results data, please see https://clinicaltrials.gov/ct2/show/NCT01431001